Prosecution Insights
Last updated: April 19, 2026
Application No. 18/340,252

RESIN COMPOSITION

Non-Final OA §102
Filed
Jun 23, 2023
Examiner
BUTCHER, ROBERT T
Art Unit
1764
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Kaneka Corporation
OA Round
1 (Non-Final)
71%
Grant Probability
Favorable
1-2
OA Rounds
2y 8m
To Grant
89%
With Interview

Examiner Intelligence

Grants 71% — above average
71%
Career Allow Rate
665 granted / 941 resolved
+5.7% vs TC avg
Strong +18% interview lift
Without
With
+18.4%
Interview Lift
resolved cases with interview
Typical timeline
2y 8m
Avg Prosecution
65 currently pending
Career history
1006
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
49.4%
+9.4% vs TC avg
§102
12.0%
-28.0% vs TC avg
§112
23.7%
-16.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 941 resolved cases

Office Action

§102
DETAILED ACTION The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . This application is a continuation of application No. PCT/JP21/47832, filed on Dec. 23, 2021. Acknowledgment is made of applicant's claim for foreign priority under 35 U.S.C. §119(a)-(d) by Application No. JP 2020-217565 and JP 2021-033814 filed 12/25/2020 and 3/3/2021 respectively, which papers have been placed of record in the file. Claims 1-11 are pending. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-11 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Okamoto et al. (US 2019/0040290). Regarding claim 1: Okamoto is directed to a resin composition comprising: Polymer particles (A) of a core/shell polymer; and A matrix resin (B) of an epoxy resin The polymer particles including Core-Shell Polymer Latex L-1 comprises a graft part comprising (i) (i-a) no structural unit containing an aromatic group and (ii) contains at least one alkyl acrylate of butylacrylate and contains no structural units of (iii). The shell graft part comprises 3 parts methylmethacrylate (MMA, Tg 105 ˚C) and 10 parts by mass butylacrylate (BA Tg -55 ˚C) and therefore the glass transition temperature can be calculated as about -1 ˚C (1/Tg=23/105+77/-55) by the well-known Flory-Fox equation. Regarding claim 2: The polymer fine particles are used in an amount of preferably 4-70 parts by mass per 100 parts by mass of the epoxy resin ([0065]). It follows the polymer particles are contained in an amount of 4-41% by weight and the matrix resin (B) is present in an amount of 6-59% by weight, wherein 100% by weight represents a total amount of polymer particles (A) and matrix resin (B). Regarding claim 3: Okamoto is directed to a resin composition comprising: Polymer particles (A) of a core/shell polymer; and A matrix resin (B) of an epoxy resin The polymer particles have a graft part Core-Shell Polymer Latex L-1 comprises a graft part comprising (i) (i-a) no structural unit containing an aromatic group and (ii) contains at least one alkyl acrylate of butylacrylate and contains no structural units of (iii). The shell graft part comprises 3 parts methylmethacrylate (MMA, Tg 105 C) and 10 parts by mass butylacrylate (BA Tg -55 C) and therefore the glass transition temperature can be calculated as about -1 ˚C (1/Tg=23/105+77/-55) by the well-known Flory-Fox equation. The polymer fine particles in Examples 1-21 comprise polymer particles in an amount of 33-50% by weight based on 100 wt% of polymer particles (A) and matrix resin (B) (Table 2). Regarding claim 4: The graft part of Core-Shell Polymer Latex L-1 contains no structural unit containing an aromatic group. Regarding claim 5: The volume average particle diameter of the polymer particles Is preferably 50 to 400 nm (0.05-0.4 μm). Examples 2-24 to 2-26 have volume average particle size of 0.21 μm (Table 1). Regarding claim 6: Examples 2-2 to 2-15 comprise more than 0 and less than 50 wt% glycidyl methacrylate (GMA) (a structural unit having an epoxy group) based on 100% by weight of the graft part. (Table 1). Regarding claim 7: The shell graft part comprises 3 parts methylmethacrylate (MMA, Tg 105 C) and 10 parts by mass butylacrylate (BA Tg -55 C) wherein the glass transition temperature can be calculated as about -1 ˚C (1/Tg=23/105+77/-55) by the well-known Flory-Fox equation, and therefore contains not less than 20% by weight of a structural unit derived from a monomer that provides a homopolymer having a glass transition temperature of not higher than 0 ˚C. Regarding claim 8: The compositions of the working examples have a viscosity of not more than 20,000 mPa.s at 50 ˚C (Table 1). Regarding claim 9: The polymer fine particles in Examples 5-21 comprise polymer particles in an amount of 40-50% by weight based on 100 wt% of polymer particles (A) and matrix resin (B) (Table 2). Regarding claim 10: An inorganic filler is disclosed ([0136]). Regarding claim 11: The matrix resin is an epoxy resin. Related Prior Art The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. The teachings of Miyatake et al. (WO 2019/123934) are relevant art but not discussed above. Miyatake is directed to the claimed resin composition as discussed in the Chinese Office Action listed on the IDS filed 5/20/2025. Contact Information Any inquiry concerning this communication or earlier communications from the examiner should be directed to ROBERT T BUTCHER whose telephone number is (571)270-3514. The examiner can normally be reached Telework M-F 9-5 Pacific Time Zone. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Lanee Reuther can be reached at (571) 270-7026. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ROBERT T BUTCHER/Primary Examiner, Art Unit 1764
Read full office action

Prosecution Timeline

Jun 23, 2023
Application Filed
Jan 03, 2026
Non-Final Rejection — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12600874
AQUEOUS PIGMENTED INK
2y 5m to grant Granted Apr 14, 2026
Patent 12600086
BINDER SYSTEM AND DEVICES FOR 3-D PRINTING AND ARTICLES PRODUCED THEREFROM
2y 5m to grant Granted Apr 14, 2026
Patent 12584001
HIGH EFFICACY CU-BASED ANTI-MICROBIAL FILMS AND SUBSTRATES AND METHODS OF MAKING THE SAME
2y 5m to grant Granted Mar 24, 2026
Patent 12577340
STORAGE STABLE TWO-COMPONENT DUAL CURE DENTAL COMPOSITION
2y 5m to grant Granted Mar 17, 2026
Patent 12577406
RESIN COMPOSITION, FILM, AND MULTILAYER STRUCTURE
2y 5m to grant Granted Mar 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
71%
Grant Probability
89%
With Interview (+18.4%)
2y 8m
Median Time to Grant
Low
PTA Risk
Based on 941 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month